跳至主要内容
临床试验/EUCTR2010-024100-10-NL
EUCTR2010-024100-10-NL进行中(未招募)1 期

Clonidine as an adjuvant to prolong local anaesthesia in ophthalmic surgery with cryocoagulation. A randomized, controlled, patient-masked trial. - Retrobulbar clonidine

The Rotterdam Eye Hospital0 个研究点目标入组 101 人开始时间: 2010年11月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
101

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Age = 18 years.
  • - Informed consent.
  • - Rhegmatogenous retinal detachment requiring cryocoagulation and episcleral explant.
  • - Glaucoma requiring cryocoagulation of the ciliary body.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Hypersensitivity to clonidine or any other ingredients in the product.
  • - Severe bradyarrhythmia as a result of sick sinus syndrome or 2nd or 3rd degree AV block.
  • - Use of oral clonidine.
  • - Cerebrovascular disease, heart failure, coronary insufficiency, occlusive peripheral vascular disorder.
  • - Lapp lactase deficiency or glucose-galactose malabsorption.
  • - Bipolar disorder.
  • - All (other) contraindications and warnings mentioned in the Summary of Product Characteristics of Catapresan.

研究者

发起方
The Rotterdam Eye Hospital

相似试验